IVVvsPBE
iShares Core S&P 500 ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IVV | PBE | |
|---|---|---|
| Expense ratio | 0.030% | 0.59% |
| Assets | $879.1B | $434M |
| Net flow, 1 month | +$10.1B | +$10M |
| Net flow, 1 year | +$71.4B | +$122M |
| Return, YTD | +8.5% | +16.6% |
| Return, 1 year | — | — |
| Avg daily volume | 5.5M | 22K |
| Holdings | 505 | 31 |
| Listed | May 15, 2000 | Jun 23, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS